BUSINESS CASES
Market Access & Pricing support for a therapy for the treatment of rare genetic disorders of obesity inFrance, Spain, Italy and UK
The overall project aim was to support the company in securing timely patient
access to the therapy at a price that is acceptable for both the company and
stakeholders in 4 European countries (France, Spain, Italy, UK).
Anticipate Market Access & Pricing for 4 new products in Germany, France, Spain, Italy and UK
The overall project aim was to support the company to register 4 new products for
Project aim the EU5 market.
Market Access & Pricing support for a therapy for the treatment of pediatric and rare diseases in Germany, France, Spain, Italy and UK
Market Access & Pricing support for a therapy for the treatment of pediatric and rare diseases in Germany, France, Spain, Italy and UK
Market Access & Pricing support for a therapy for the treatment of neuroendocrine tumors in 5 European countries (France, Spain, Italy, UK and Germany).
The overall project aim was to support the company in securing timely patient access to the therapy at a price that is acceptable for both the company and stakeholders in EU5 (France, Spain, Italy, UK and Germany).
Market Access & Pricing support for plasma-derived medicines in France and Spain.
The overall project aim was to support the company in the launch of their therapy in 2 European countries (France and Spain) in the context of shortages and supply tensions of the raw material.
